Sensus Healthcare Blog

May Is National Skin Cancer Awareness Month

By Michelle Verina | Published: May 17, 2013
May is Skin Cancer Awareness Month

May is Skin Cancer Awareness Month!

As the month of May brings skin cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated skin cancer information throughout the year.

Cancer of the skin is often divided into two categories: non-melanoma and melanoma. The American Cancer Society (ACS) estimates there are well over 1 million unreported cases of non-melanoma (basal cell or squamous cell) cancers annually annually in the United States. Melanoma, the more-serious form of skin cancer, was expected to be diagnosed in close to 70,000 people in 2009. The ACS also estimated that approximately 11,500 deaths would occur in 2009 from all forms of skin cancer combined (8,650 from melanoma and 2,940 from non-melanoma).

Sensus Healthcare offers a new non-invasive treatment for non-melanoma skin cancer. The SRT-100 (Superficial Radiotherapy) provide fast and painless treatment options for patients.

Please ask your dermatologist for more information on the SRT-100!

Posted in News | Tagged , , , , , | Comments closed

Squamous Cell Carcinoma On the Right Hand

By Michelle Verina | Published: May 10, 2013

Squamous cell carcinoma (SCC) is an uncontrolled growth of abnormal cells arising in the squamous cells, which compose most of the skin’s upper layers (the epidermis).  Squamous Cell Carcinoma often look like scaly red patches, open sores, elevated growths with a central depression, or warts; they may crust or bleed.

SCC Before SCC After

This form of skin cancer is mainly caused by cumulative UV exposure over the course of a lifetime. It can become disfiguring and sometimes deadly if allowed to grow. An estimated 700,000 cases of Squamous Cell Carcinoma are diagnosed each year in the US, resulting in approximately 2,500 deaths.

Squamous Cell Carcinoma may occur on all areas of the body including the mucous membranes and genitals, but are most common in areas frequently exposed to the sun, such as the rim of the ear, lower lip, face, bald scalp, neck, hands, arms and legs. Often the skin in these areas reveals telltale signs of sun damage, such as wrinkling, changes in pigmentation, and loss of elasticity.

If you have been diagnosed with Squamous Cell Carcinoma; surgery is NOT your only option. The SRT-100™ provides non-invasive treatment options that are cosmetically preferential. 

  • SAFE
  • EFFECTIVE
  • NON-SURGICAL
  • FAST

Ask your dermatologist for more information on the SRT-100™! 

Posted in Blog | Tagged , , , , | Comments closed

Basal Cell Carcinoma: Nose

By Michelle Verina | Published: May 2, 2013

There are an estimated 2.8 million cases of Basal Cell Carcinoma’s diagnosed in the US each year. In fact, it is the most frequently occurring form of all cancers. More than one out of every three new cancers are skin cancers, and the vast majorities are Basal Cell Carcinomas.

Basil Cell Carcinoma Before Basil Cell Carcinoma After

Basal Cell Carcinomas are abnormal, uncontrolled growths or lesions that arise in the skin’s basal cells, which line the deepest layer of the epidermis (the outermost layer of the skin). Basal Cell Carcinomas often look like open sores, red patches, pink growths, shiny bumps, or scars. This form of skin cancer is usually caused by a combination of cumulative UV exposure and intense/ occasional UV exposure.

If you have been diagnosed with Basal Cell Carcinoma; surgery is NOT your only option. The SRT-100™ provides non-invasive treatment options that are cosmetically preferential.  The mobile and compact SRT-100™ helps bring safe, painless and effective non-melanoma skin cancer treatment to patients, right in the physician’s office.

Ask your dermatologist!

Posted in Blog | Tagged , , | Comments closed

11th Annual South Beach Symposium

By Michelle Verina | Published: April 17, 2013

A message from Joe Sardano, CEO:

Another great week at Sensus as we attended the South Beach Symposium. Three great  presentations were delivered by key physician users that created a lot of excitement amongst the attendees. The medical community is graciously accepting SRT as a viable choice in the treatment of skin cancer. This valuable tool continues to provide results that both patients & physicians are very excited about. The Technology cures skin cancer non-surgically & more patients are demanding it.

Our thoughts & prayers go out to the bombing victims in Boston. Thanks to all the volunteers.

SBS BOOTH 2013 & first responders. God Bless America!!

Posted in Events | Tagged , | Comments closed

Welcome to New Q1 2013 Customers | SRT-100 Skin Cancer Treatment System

By Michelle Verina | Published: April 4, 2013

Sensus Healthcare - Superficial Radiotherapy

I want to welcome all our new customers from Q1 who have signed up to receive our SRT-100 Skin Cancer Treatment System. We thank you for your business and we look forward to a great relationship. Also want to pass along our best wishes and congratulations to Dr. Mark Lebwohl of Mount Sinai Hospital in NYC. Dr. Lebwohl has been announced as the AAD President Elect as voted by his peers. Dr. Lebwohl is a Sensus customer and we are excited for his new appointment and we wish him well. We are looking forward to next week’s meeting in Miami, The South Beach Symposium (SBS) as we will have several presentations on behalf of SRT. We invite you to visit our booth at the SBS.

Lastly, now that baseball season has begun, enjoy your favorite teams and don’t forget to wear a hat & apply plenty of sunscreen! Play Ball!

Posted in News | Comments closed

AAD Tradeshow

By Michelle Verina | Published: March 7, 2013

ADD Tradeshow

Posted in News | Comments closed

Sensus Healthcare Announces its Exhibitor Attendance at the 71st Annual American Academy of Dermatology Meeting

By Michelle Verina | Published: February 27, 2013
Location: Miami Beach Convention Center
Date: 03/01/2013   Time: 08:00 AM

Sensus Healthcare is proud to announce their exhibitor participation in the 71st Annual American Academy of Dermatology Meeting in Miami Beach, FL on March 1-5, 2013. Visit booth #2701 to learn more about the advanced SRT-100™ superficial radiotherapy platform, featuring SharpBeam™. The SRT-100 offers unique features and benefits providing Dermatologists a non-invasive option for treating their patients who are diagnosed with skin cancer!

We cordially invite all AAD attendees to visit our booth (#2701) at the upcoming 71st Annual Academy of Dermatology Meeting in Miami Beach, FL and rediscover superficial radiotherapy (SRT). We are proud to feature our SRT-100™ non-invasive treatment system and demonstrate the impact it can have on your practice by providing your patients with a non-invasive treatment option while at the same time increasing your productivity and realizing an excellent ROI! “We are very excited by the feedback we are getting from our Dermatology customers. They are experiencing excellent outcomes as their patients are very happy with the results and they feel their investment in the SRT-100 was well worth it,” declared Joe Sardano , President/CEO, Sensus Healthcare.     
See you in Miami!

About Sensus Healthcare:

Sensus Healthcare is the worldwide leader dedicated to Superficial Radiotherapy Technology (SRT). The featured SRT-100 System is the most advanced non-invasive technology used by Dermatologists and Radiation Oncologists throughout the world in treating Basal Cell (BCC) and Squamous Cell (SCC) Carcinomas. The SRT-100 features SharpBeam technology providing the most accurate and safest treatment possible resulting in proven outcomes. Visit our web site to learn more about Sensus Healthcare…………..Taking new aim at treating skin cancer!  www.sensushealthcare.com 

Media Contact:  

Michelle Verina   
Public Relations   
561-922-5808 Ext. *100   
michelle@sensushealthcare.com

Posted in Events, News | Comments closed

Breakthrough Skin Cancer Treatment Available In Knoxville

By Michelle Verina | Published: February 14, 2013

Courtesy of WATE, Knoxville, TN – A Knoxville dermatology office is the first in Tennessee to get a breakthrough treatment for most types of skin cancer. Dr. Drew Miller, of Dermatology Associates of Knoxville, discusses why the Sensus Healthcare SRT-100™ is the quickest, most cost effective, and easiest option yet for patients who’ve been diagnosed with basal cell carcinoma or squamous cell skin cancer.

Posted in Multimedia | Comments closed

Dermatology Associates Of Knoxville SRT-100™ Commercial

By Michelle Verina | Published: February 14, 2013

Dermatology Associates of Knoxville’s SRT-100™ commercial clip for non-surgical NMSC skin cancer treatment with Dr. Miller.

Posted in Multimedia | Comments closed

Dr. Gary D. Monheit – The Role Of SRT In Dermatology

By Sensus Healthcare | Published: February 14, 2013

Dr. Gary Monheit shares his vision and insights on how superficial radiotherapy (SRT) augments the dermatology practice and the way it benefits the patient.

Posted in Multimedia | Comments closed